nach oben

Head and Neck Pathology

Erschienen in:

01.03.2014 | Original Paper

Among Sinonasal Tumors, CDX-2 Immunoexpression is not Restricted to Intestinal-Type Adenocarcinomas

verfasst von: Matthew P. Tilson, Gary L. Gallia, Justin A. Bishop

Erschienen in: Head and Neck Pathology | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Intestinal-type adenocarcinoma (ITAC) is a rare form of sinonasal cancer characterized by an association with exposure to industrial dusts, aggressive clinical behavior, and histologic/immunophenotypic similarity to tumors of the gastrointestinal tract. ITAC is sometimes very poorly differentiated and difficult to distinguish from other sinonasal neoplasms, particularly in a limited biopsy. CDX-2 and cytokeratin 20 are consistently immunoreactive in ITAC and as a result, these immunostains are often used to support the diagnosis. However, CDX-2 and cytokeratin 20 have not been tested on a broad range of sinonasal tumors, so their specificities remain unknown. Immunohistochemistry for CDX-2 and cytokeratin 20 was performed on 6 sinonasal ITACs as well as 176 non-intestinal-type sinonasal neoplasms. CDX-2 and cytokeratin 20 were positive in all 6 cases of ITAC. CDX-2 immunoexpression was also observed in 17 of 176 (10 %) non-intestinal-type tumors including 6 of 16 (38 %) sinonasal undifferentiated carcinomas, 8 of 81 (10 %) squamous cell carcinomas (including 5 of 39 non-keratinizing variants), 2 of 20 (10 %) salivary-type adenocarcinomas, and 1 of 2 (50 %) small cell carcinomas. In contrast, among non-intestinal types of sinonasal tumors, cytokeratin 20 was only focally observed in 1 of 176 non-intestinal tumors (a non-keratinizing squamous cell carcinoma). All cases of non-intestinal surface-derived adenocarcinoma and esthesioneuroblastoma were negative for both markers. Both CDX-2 and cytokeratin 20 are highly sensitive for the diagnosis of sinonasal ITAC, but cytokeratin 20 is more specific. CDX-2 staining may be observed in other high grade tumor types, especially sinonasal undifferentiated carcinoma and non-keratinizing squamous cell carcinoma. As a result, in the setting of a poorly differentiated sinonasal carcinoma the diagnosis of ITAC should not be based on CDX-2 immunoexpression alone. Clear-cut glandular differentiation and cytokeratin 20 immunoexpression are more reliable features.

Franchi A, Santucci M, Wenig BM. Intestinal-type adenocarcinomas. In: Barnes L, Eveson JW, Reichart P, Sidranksy D, editors. World Health Organization classification of tumours: pathology and genetics of head and neck tumours. Lyon: IARC Press; 2005. p. 20−2.

Franchi A, Gallo O, Santucci M. Clinical relevance of the histological classification of sinonasal intestinal-type adenocarcinomas. Hum Pathol. 1999;30(10):1140–5.PubMedCrossRef

Barnes L. Intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Am J Surg Pathol. 1986;10(3):192–202.PubMedCrossRef

Urso C, Ninu MB, Franchi A, Paglierani M, Bondi R. Intestinal-type adenocarcinoma of the sinonasal tract: a clinicopathologic study of 18 cases. Tumori. 1993;79(3):205–10.PubMed

Stelow EB, Mills SE. Neural, neuroectodermal, and neuroendocrine neoplasms. Biopsy interpretation of the upper aerodigestive tract and ear. Philadelphia: Lippincott Williams & Wilkins; 2008. p. 149.

Franquemont DW, Fechner RE, Mills SE. Histologic classification of sinonasal intestinal-type adenocarcinoma. Am J Surg Pathol. 1991;15(4):368–75.PubMedCrossRef

Kleinsasser O, Schroeder HG. Adenocarcinomas of the inner nose after exposure to wood dust. Morphological findings and relationships between histopathology and clinical behavior in 79 cases. Arch Otorhinolaryngol. 1988;245(1):1–15.PubMedCrossRef

Franchi A, Fondi C, Paglierani M, Pepi M, Gallo O, Santucci M. Epidermal growth factor receptor expression and gene copy number in sinonasal intestinal type adenocarcinoma. Oral Oncol. 2009;45(9):835–8. doi:10.1016/j.oraloncology.2008.12.005.PubMedCrossRef

Szablewski V, Solassol J, Poizat F, Larrieux M, Crampette L, Mange A, et al. EGFR Expression and KRAS and BRAF Mutational Status in Intestinal-Type Sinonasal Adenocarcinoma. Int J Mol Sci. 2013;14(3):5170–81. doi:10.3390/ijms14035170.PubMedCentralPubMedCrossRef

10.

Garcia-Inclan C, Lopez F, Perez-Escuredo J, Cuesta-Albalad MP, Vivanco B, Centeno I, et al. EGFR status and KRAS/BRAF mutations in intestinal-type sinonasal adenocarcinomas. Cell Oncol (Dordr). 2012;35(6):443–50. doi:10.1007/s13402-012-0103-7.PubMedCrossRef

11.

Health. NIfOSa. Health effects of exposure to wood dust: a summary of the literature. Washington, D.C.: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, Division of Standards Development and Technology Transfer; 1987.

12.

Kleinsasser O, Schroeder HG, Mayer-Brix J. Preinvasive stages of adenocarcinoma of the nose after exposure to wood dust. Eur Arch Otorhinolaryngol. 1991;248(4):222–9.PubMedCrossRef

13.

d’Errico A, Pasian S, Baratti A, Zanelli R, Alfonzo S, Gilardi L, et al. A case-control study on occupational risk factors for sino-nasal cancer. Occup Environ Med. 2009;66(7):448–55. doi:10.1136/oem.2008.041277.PubMedCentralPubMedCrossRef

14.

Bonneterre V, Deschamps E, Persoons R, Bernardet C, Liaudy S, Maitre A, et al. Sino-nasal cancer and exposure to leather dust. Occup Med (Lond). 2007;57(6):438–43. doi:10.1093/occmed/kqm050.PubMedCrossRef

15.

Cathro HP, Mills SE. Immunophenotypic differences between intestinal-type and low-grade papillary sinonasal adenocarcinomas: an immunohistochemical study of 22 cases utilizing CDX2 and MUC2. Am J Surg Pathol. 2004;28(8):1026–32.PubMedCrossRef

16.

Franchi A, Massi D, Baroni G, Santucci M. CDX-2 homeobox gene expression. Am J Surg Pathol. 2003;27(10):1390–1.PubMedCrossRef

17.

Franchi A, Massi D, Palomba A, Biancalani M, Santucci M. CDX-2, cytokeratin 7 and cytokeratin 20 immunohistochemical expression in the differential diagnosis of primary adenocarcinomas of the sinonasal tract. Virchows Archiv Int J pathol. 2004;445(1):63–7. doi:10.1007/s00428-004-1030-4.

18.

Kennedy MT, Jordan RC, Berean KW, Perez-Ordonez B. Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma. J Clin Pathol. 2004;57(9):932–7. doi:10.1136/jcp.2004.016964.PubMedCentralPubMedCrossRef

19.

Ortiz-Rey JA, Alvarez C, San Miguel P, Iglesias B, Anton I. Expression of CDX2, cytokeratins 7 and 20 in sinonasal intestinal-type adenocarcinoma. Appl Immunohistochem Mol Morphol. 2005;13(2):142–6.PubMedCrossRef

20.

Werling RW, Yaziji H, Bacchi CE, Gown AM. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol. 2003;27(3):303–10.PubMedCrossRef

21.

Bishop JA, Guo TW, Smith DF, Wang H, Ogawa T, Pai SI, et al. Human papillomavirus-related carcinomas of the sinonasal tract. Am J Surg Pathol. 2013;37(2):185–92. doi:10.1097/PAS.0b013e3182698673.PubMedCentralPubMedCrossRef

22.

Barnes L, Tse LLY, Hunt JL, Brandwein-Gensler M, Curtin HD, Boffetta P. Tumours of the nasal cavity and paranasal sinuses: introduction. In: Barnes L, Eveson JW, Reichart P, Sidranksy D, editors. World Health Organization classification of tumours: Pathology and genetics of head and neck tumours. Lyon: IARC Press; 2005. p. 12–5.

23.

Scholl C, Bansal D, Dohner K, Eiwen K, Huntly BJ, Lee BH, et al. The homeobox gene CDX2 is aberrantly expressed in most cases of acute myeloid leukemia and promotes leukemogenesis. J Clin Investig. 2007;117(4):1037–48. doi:10.1172/JCI30182.PubMedCentralPubMedCrossRef

24.

Riedt T, Ebinger M, Salih HR, Tomiuk J, Handgretinger R, Kanz L, et al. Aberrant expression of the homeobox gene CDX2 in pediatric acute lymphoblastic leukemia. Blood. 2009;113(17):4049–51. doi:10.1182/blood-2008-12-196634.PubMedCrossRef

25.

Wani Y, Notohara K, Saegusa M, Tsukayama C. Aberrant Cdx2 expression in endometrial lesions with squamous differentiation: important role of Cdx2 in squamous morula formation. Hum Pathol. 2008;39(7):1072–9. doi:10.1016/j.humpath.2007.07.019.PubMedCrossRef

26.

Bongiovanni M, Piana S, Frattini M, Giovanella L, Spitale A, Ragazzi M, et al. CDX2 expression in columnar variant of papillary thyroid carcinoma. Thyroid. 2013;. doi:10.1089/thy.2013.0146.

27.

Sujoy V, Pinto A, Nose V. Columnar cell variant of papillary thyroid carcinoma: a study of 10 cases with emphasis on CDX2 expression. Thyroid. 2013;23(6):714–9. doi:10.1089/thy.2012.0455.PubMedCrossRef

28.

Cameselle-Teijeiro J, Alberte-Lista L, Peteiro-Gonzalez D, Abdulkader-Nallib I, Reyes-Santias R, Soares P et al. CDX2 expression in some variants of papillary thyroid carcinoma. Am J Clin Pathol. 2012;138(6):907–9; author reply p. 10. doi:10.1309/AJCP1BGCA6MFCNKH.

29.

Enriquez ML, Baloch ZW, Montone KT, Zhang PJ, LiVolsi VA. CDX2 expression in columnar cell variant of papillary thyroid carcinoma. Am J Clin Pathol. 2012;137(5):722–6. doi:10.1309/AJCPXE3PUBWVZCGZ.PubMedCrossRef

30.

Steininger H, Mueller H, Marquardt L. Aberrant expression of CDX2 in metaplastic and inflammatory epithelium of the urinary bladder. Am J Surg Pathol. 2005;29(9):1252.PubMedCrossRef

Titel: Among Sinonasal Tumors, CDX-2 Immunoexpression is not Restricted to Intestinal-Type Adenocarcinomas
verfasst von: Matthew P. Tilson
Gary L. Gallia
Justin A. Bishop
Publikationsdatum: 01.03.2014
Verlag: Springer US
Erschienen in: Head and Neck Pathology / Ausgabe 1/2014
Elektronische ISSN: 1936-0568
DOI: https://doi.org/10.1007/s12105-013-0475-7

Springer Medizin

Among Sinonasal Tumors, CDX-2 Immunoexpression is not Restricted to Intestinal-Type Adenocarcinomas

Abstract

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren

Personalisierte Medizin in der Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2014

Apocrine Hidrocystoma of the Lower Lip: A Case Report and Literature Review

Current Views and Perspectives on Classification of Squamous Intraepithelial Lesions of the Head and Neck

The Association of Warthin Tumor with Salivary Ductal Inclusions in Intra and Periparotid Lymph Nodes

Human Papillomavirus-Associated Head and Neck Squamous Cell Carcinoma Survival: A Comparison by Tumor Site and Initial Treatment

Salivary Gland Tumor “Wishes” to Add to the Next WHO Tumor Classification: Sclerosing Polycystic Adenosis, Mammary Analogue Secretory Carcinoma, Cribriform Adenocarcinoma of the Tongue and Other Sites, and Mucinous Variant of Myoepithelioma

Acetylated Tubulin (AT) as a Prognostic Marker in Squamous Cell Carcinoma of the Head and Neck

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren

Personalisierte Medizin in der Onkologie